PRTK - Paratek Pharmaceuticals GAAP EPS of -$0.25 revenue of $40M August, 03 2023 10:02 AM Paratek Pharmaceuticals Inc. 2023-08-03 10:02:09 ET Paratek Pharmaceuticals press release ( NASDAQ: PRTK ): Q2 GAAP EPS of -$0.25. Revenue of $40M (+35.1% Y/Y). For further details see: Paratek Pharmaceuticals GAAP EPS of -$0.25, revenue of $40M